Heterologous expression systems for studying placental transporters.

Vadivel Ganapathy, You Jun Fei, Puttur D Prasad

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We use two different heterologous expression systems to characterize the functional features of plasma membrane transporters cloned from placenta. The first is the vaccinia virus expression system that utilizes a recombinant vaccinia virus carrying a transgene for T7 RNA polymerase. Mammalian cells, when infected with this virus, are able to produce T7 RNA polymerase. If these cells are then transfected with a transporter cDNA which is under the control of T7 promoter in the plasmid, the T7 RNA polymerase will transcribe the cDNA and the cellular machinery will synthesize the transporter protein from the resultant mRNA and target it to the plasma membrane. The transport function of the heterologously expressed transporter can then be monitored by uptake of suitable substrates in these cells. The second is the Xenopus laevis oocyte expression system in which any transporter can be expressed heterologously by injection of the oocytes with corresponding cRNA. The functional features of the expressed transporter can then be monitored either by uptake of suitable substrates or by electrophysiological means if the transporter function is electrogenic. Both methods are complementary to each other and together provide an effective means to delineate the functional features of various transporters, irrespective of their independent transport mechanisms.

Original languageEnglish (US)
Pages (from-to)285-300
Number of pages16
JournalMethods in molecular medicine
Volume122
StatePublished - Jan 1 2006

Fingerprint

Vaccinia virus
Oocytes
Complementary DNA
Cell Membrane
Complementary RNA
Membrane Transport Proteins
Xenopus laevis
Transgenes
Placenta
Plasmids
Viruses
Messenger RNA
Injections
bacteriophage T7 RNA polymerase
Proteins

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Heterologous expression systems for studying placental transporters. / Ganapathy, Vadivel; Fei, You Jun; Prasad, Puttur D.

In: Methods in molecular medicine, Vol. 122, 01.01.2006, p. 285-300.

Research output: Contribution to journalArticle

@article{ae906bed6b3d4b94b934d6b4dc55f3f8,
title = "Heterologous expression systems for studying placental transporters.",
abstract = "We use two different heterologous expression systems to characterize the functional features of plasma membrane transporters cloned from placenta. The first is the vaccinia virus expression system that utilizes a recombinant vaccinia virus carrying a transgene for T7 RNA polymerase. Mammalian cells, when infected with this virus, are able to produce T7 RNA polymerase. If these cells are then transfected with a transporter cDNA which is under the control of T7 promoter in the plasmid, the T7 RNA polymerase will transcribe the cDNA and the cellular machinery will synthesize the transporter protein from the resultant mRNA and target it to the plasma membrane. The transport function of the heterologously expressed transporter can then be monitored by uptake of suitable substrates in these cells. The second is the Xenopus laevis oocyte expression system in which any transporter can be expressed heterologously by injection of the oocytes with corresponding cRNA. The functional features of the expressed transporter can then be monitored either by uptake of suitable substrates or by electrophysiological means if the transporter function is electrogenic. Both methods are complementary to each other and together provide an effective means to delineate the functional features of various transporters, irrespective of their independent transport mechanisms.",
author = "Vadivel Ganapathy and Fei, {You Jun} and Prasad, {Puttur D}",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "122",
pages = "285--300",
journal = "Methods in molecular medicine.",
issn = "1543-1894",
publisher = "Humana Press",

}

TY - JOUR

T1 - Heterologous expression systems for studying placental transporters.

AU - Ganapathy, Vadivel

AU - Fei, You Jun

AU - Prasad, Puttur D

PY - 2006/1/1

Y1 - 2006/1/1

N2 - We use two different heterologous expression systems to characterize the functional features of plasma membrane transporters cloned from placenta. The first is the vaccinia virus expression system that utilizes a recombinant vaccinia virus carrying a transgene for T7 RNA polymerase. Mammalian cells, when infected with this virus, are able to produce T7 RNA polymerase. If these cells are then transfected with a transporter cDNA which is under the control of T7 promoter in the plasmid, the T7 RNA polymerase will transcribe the cDNA and the cellular machinery will synthesize the transporter protein from the resultant mRNA and target it to the plasma membrane. The transport function of the heterologously expressed transporter can then be monitored by uptake of suitable substrates in these cells. The second is the Xenopus laevis oocyte expression system in which any transporter can be expressed heterologously by injection of the oocytes with corresponding cRNA. The functional features of the expressed transporter can then be monitored either by uptake of suitable substrates or by electrophysiological means if the transporter function is electrogenic. Both methods are complementary to each other and together provide an effective means to delineate the functional features of various transporters, irrespective of their independent transport mechanisms.

AB - We use two different heterologous expression systems to characterize the functional features of plasma membrane transporters cloned from placenta. The first is the vaccinia virus expression system that utilizes a recombinant vaccinia virus carrying a transgene for T7 RNA polymerase. Mammalian cells, when infected with this virus, are able to produce T7 RNA polymerase. If these cells are then transfected with a transporter cDNA which is under the control of T7 promoter in the plasmid, the T7 RNA polymerase will transcribe the cDNA and the cellular machinery will synthesize the transporter protein from the resultant mRNA and target it to the plasma membrane. The transport function of the heterologously expressed transporter can then be monitored by uptake of suitable substrates in these cells. The second is the Xenopus laevis oocyte expression system in which any transporter can be expressed heterologously by injection of the oocytes with corresponding cRNA. The functional features of the expressed transporter can then be monitored either by uptake of suitable substrates or by electrophysiological means if the transporter function is electrogenic. Both methods are complementary to each other and together provide an effective means to delineate the functional features of various transporters, irrespective of their independent transport mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=33645947642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645947642&partnerID=8YFLogxK

M3 - Article

VL - 122

SP - 285

EP - 300

JO - Methods in molecular medicine.

JF - Methods in molecular medicine.

SN - 1543-1894

ER -